Loading...
Header Logo
Keywords
Last Name
Institution

Alan Schneyer M.S., Ph.D.

TitleResearch Professor
InstitutionUniversity of Massachusetts Amherst
DepartmentCollege of Natural Sciences
Address431 Integrated Science Center
Amherst, MA 01003
Phone617-922-5384
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Li Y, Fortin J, Ongaro L, Zhou X, Boehm U, Schneyer A, Bernard DJ, Lin HY. Betaglycan (TGFBR3) functions as an inhibin A, but not inhibin B, co-receptor in pituitary gonadotrope cells in mice. Endocrinology. 2018 Oct 25. PMID: 30364975.
      View in: PubMed
    2. Meng C, Liu W, Huang H, Wang Y, Chen B, Freeman GJ, Schneyer A, Lin HY, Xia Y. Repulsive Guidance Molecule b (RGMb) Is Dispensable for Normal Gonadal Function in Mice. Biol Reprod. 2016 Apr; 94(4):78. PMID: 26911425.
      View in: PubMed
    3. Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice. Endocrinology. 2016 Mar; 157(3):1146-62. PMID: 26735394.
      View in: PubMed
    4. Brown ML, Andrzejewski D, Burnside A, Schneyer AL. Activin Enhances a- to ß-Cell Transdifferentiation as a Source For ß-Cells In Male FSTL3 Knockout Mice. Endocrinology. 2016 Mar; 157(3):1043-54. PMID: 26727106.
      View in: PubMed
    5. Andrzejewski D, Brown ML, Ungerleider N, Burnside A, Schneyer AL. Activins A and B Regulate Fate-Determining Gene Expression in Islet Cell Lines and Islet Cells From Male Mice. Endocrinology. 2015 Jul; 156(7):2440-50. PMID: 25961841.
      View in: PubMed
    6. Nam J, Perera P, Gordon R, Jeong YH, Blazek AD, Kim DG, Tee BC, Sun Z, Eubank TD, Zhao Y, Lablebecioglu B, Liu S, Litsky A, Weisleder NL, Lee BS, Butterfield T, Schneyer AL, Agarwal S. Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening. Bone. 2015 Sep; 78:62-70. PMID: 25937185.
      View in: PubMed
    7. Meng C, Guo N, Wei Q, Shi F, Schneyer AL, Xia Y, Mao D. Expression of repulsive guidance molecule b (RGMb) in the uterus and ovary during the estrous cycle in rats. Acta Histochem. 2014 Oct; 116(8):1231-6. PMID: 25085051.
      View in: PubMed
    8. Brown ML, Ungerleider N, Bonomi L, Andrzejewski D, Burnside A, Schneyer A. Effects of activin A on survival, function and gene expression of pancreatic islets from non-diabetic and diabetic human donors. Islets. 2014; 6(5-6):e1017226. PMID: 25833251.
      View in: PubMed
    9. Ungerleider NA, Bonomi LM, Brown ML, Schneyer AL. Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice. Endocrinology. 2013 Jun; 154(6):2025-33. PMID: 23533219.
      View in: PubMed
    10. Oldknow KJ, Seebacher J, Goswami T, Villen J, Pitsillides AA, O'Shaughnessy PJ, Gygi SP, Schneyer AL, Mukherjee A. Follistatin-like 3 (FSTL3) mediated silencing of transforming growth factor ß (TGFß) signaling is essential for testicular aging and regulating testis size. Endocrinology. 2013 Mar; 154(3):1310-20. PMID: 23407452.
      View in: PubMed
    11. Bonomi L, Brown M, Ungerleider N, Muse M, Matzuk MM, Schneyer A. Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity. Am J Physiol Endocrinol Metab. 2012 Sep 1; 303(5):E587-96. PMID: 22739106.
      View in: PubMed
    12. Brown ML, Kimura F, Bonomi LM, Ungerleider NA, Schneyer AL. Differential synthesis and action of TGFß superfamily ligands in mouse and rat islets. Islets. 2011 Nov-Dec; 3(6):367-75. PMID: 21964310.
      View in: PubMed
    13. Schneyer A. Getting big on BPA: role for BPA in obesity? Endocrinology. 2011 Sep; 152(9):3301-3. PMID: 21862570.
      View in: PubMed
    14. Brown ML, Bonomi L, Ungerleider N, Zina J, Kimura F, Mukherjee A, Sidis Y, Schneyer A. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obesity (Silver Spring). 2011 Oct; 19(10):1940-9. PMID: 21546932.
      View in: PubMed
    15. Dunphy KA, Schneyer AL, Hagen MJ, Jerry DJ. The role of activin in mammary gland development and oncogenesis. J Mammary Gland Biol Neoplasia. 2011 Jun; 16(2):117-26. PMID: 21475961.
      View in: PubMed
    16. Kimura F, Bonomi LM, Schneyer AL. Follistatin regulates germ cell nest breakdown and primordial follicle formation. Endocrinology. 2011 Feb; 152(2):697-706. PMID: 21106872.
      View in: PubMed
    17. Dasarathy S, McCullough AJ, Muc S, Schneyer A, Bennett CD, Dodig M, Kalhan SC. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J Hepatol. 2011 May; 54(5):915-21. PMID: 21145817.
      View in: PubMed
    18. Brown ML, Schneyer AL. Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis. Trends Endocrinol Metab. 2010 Jul; 21(7):441-8. PMID: 20382030.
      View in: PubMed
    19. Xia Y, Babitt JL, Bouley R, Zhang Y, Da Silva N, Chen S, Zhuang Z, Samad TA, Brenner GJ, Anderson JL, Hong CC, Schneyer AL, Brown D, Lin HY. Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells. J Am Soc Nephrol. 2010 Apr; 21(4):666-77. PMID: 20167703.
      View in: PubMed
    20. vom Saal FS, Akingbemi BT, Belcher SM, Crain DA, Crews D, Guidice LC, Hunt PA, Leranth C, Myers JP, Nadal A, Olea N, Padmanabhan V, Rosenfeld CS, Schneyer A, Schoenfelder G, Sonnenschein C, Soto AM, Stahlhut RW, Swan SH, Vandenberg LN, Wang HS, Watson CS, Welshons WV, Zoeller RT. Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci. 2010 Jun; 115(2):612-3; author reply 614-20. PMID: 20164146.
      View in: PubMed
    21. Kimura F, Sidis Y, Bonomi L, Xia Y, Schneyer A. The follistatin-288 isoform alone is sufficient for survival but not for normal fertility in mice. Endocrinology. 2010 Mar; 151(3):1310-9. PMID: 20032047.
      View in: PubMed
    22. Thadhani R, Powe CE, Tjoa ML, Khankin E, Ye J, Ecker J, Schneyer A, Karumanchi SA. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care. 2010 Mar; 33(3):664-9. PMID: 20007937.
      View in: PubMed
    23. Xia Y, Schneyer AL. The biology of activin: recent advances in structure, regulation and function. J Endocrinol. 2009 Jul; 202(1):1-12. PMID: 19273500.
      View in: PubMed
    24. Stamler R, Keutmann HT, Sidis Y, Kattamuri C, Schneyer A, Thompson TB. The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity. J Biol Chem. 2008 Nov 21; 283(47):32831-8. PMID: 18768470.
      View in: PubMed
    25. Schneyer AL, Sidis Y, Gulati A, Sun JL, Keutmann H, Krasney PA. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology. 2008 Sep; 149(9):4589-95. PMID: 18535106.
      View in: PubMed
    26. Lambert-Messerlian G, Eklund E, Pinar H, Tantravahi U, Schneyer AL. Activin subunit and receptor expression in normal and cleft human fetal palate tissues. Pediatr Dev Pathol. 2007 Nov-Dec; 10(6):436-45. PMID: 18001154.
      View in: PubMed
    27. Xia Y, Yu PB, Sidis Y, Beppu H, Bloch KD, Schneyer AL, Lin HY. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. J Biol Chem. 2007 Jun 22; 282(25):18129-40. PMID: 17472960.
      View in: PubMed
    28. Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1348-53. PMID: 17229845.
      View in: PubMed
    29. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology. 2006 Jul; 147(7):3586-97. PMID: 16627583.
      View in: PubMed
    30. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006 May; 38(5):531-9. PMID: 16604073.
      View in: PubMed
    31. Saito S, Sidis Y, Mukherjee A, Xia Y, Schneyer A. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. Endocrinology. 2005 Dec; 146(12):5052-62. PMID: 16150905.
      View in: PubMed
    32. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM, Schneyer AL. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab. 2005 Oct; 90(10):5582-7. PMID: 16030174.
      View in: PubMed
    33. Babitt JL, Zhang Y, Samad TA, Xia Y, Tang J, Campagna JA, Schneyer AL, Woolf CJ, Lin HY. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem. 2005 Aug 19; 280(33):29820-7. PMID: 15975920.
      View in: PubMed
    34. Xia Y, Sidis Y, Mukherjee A, Samad TA, Brenner G, Woolf CJ, Lin HY, Schneyer A. Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis. Endocrinology. 2005 Aug; 146(8):3614-21. PMID: 15890774.
      View in: PubMed
    35. Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL, Lin HY, Brivanlou AH, Attisano L, Woolf CJ. DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem. 2005 Apr 8; 280(14):14122-9. PMID: 15671031.
      View in: PubMed
    36. Schneyer A, Sidis Y, Xia Y, Saito S, del Re E, Lin HY, Keutmann H. Differential actions of follistatin and follistatin-like 3. Mol Cell Endocrinol. 2004 Oct 15; 225(1-2):25-8. PMID: 15451564.
      View in: PubMed
    37. del Re E, Sidis Y, Fabrizio DA, Lin HY, Schneyer A. Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system. J Biol Chem. 2004 Dec 17; 279(51):53126-35. PMID: 15475360.
      View in: PubMed
    38. Sidis Y, Schneyer AL, Keutmann HT. Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology. 2005 Jan; 146(1):130-6. PMID: 15471966.
      View in: PubMed
    39. Schneyer AL, Wang Q, Sidis Y, Sluss PM. Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab. 2004 Oct; 89(10):5067-75. PMID: 15472207.
      View in: PubMed
    40. Schneyer A. Inhibins: a historical perspective. Semin Reprod Med. 2004 Aug; 22(3):161-4. PMID: 15319818.
      View in: PubMed
    41. del Re E, Babitt JL, Pirani A, Schneyer AL, Lin HY. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. J Biol Chem. 2004 May 21; 279(21):22765-72. PMID: 14996829.
      View in: PubMed
    42. Xia Y, Sidis Y, Schneyer A. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice. Mol Endocrinol. 2004 Apr; 18(4):979-94. PMID: 14739256.
      View in: PubMed
    43. Welt CK, Schneyer AL, Heist K, Mantzoros CS. Leptin and soluble leptin receptor in follicular fluid. J Assist Reprod Genet. 2003 Dec; 20(12):495-501. PMID: 15035548.
      View in: PubMed
    44. Keutmann HT, Schneyer AL, Sidis Y. The role of follistatin domains in follistatin biological action. Mol Endocrinol. 2004 Jan; 18(1):228-40. PMID: 14563935.
      View in: PubMed
    45. Schneyer A, Schoen A, Quigg A, Sidis Y. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology. 2003 May; 144(5):1671-4. PMID: 12697670.
      View in: PubMed
    46. Seifer DB, Lambert-Messerlian G, Schneyer AL. Ovarian brain-derived neurotrophic factor is present in follicular fluid from normally cycling women. Fertil Steril. 2003 Feb; 79(2):451-2. PMID: 12568867.
      View in: PubMed
    47. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood). 2002 Oct; 227(9):724-52. PMID: 12324653.
      View in: PubMed
    48. Di Simone N, Schneyer AL, Caliandro D, Castellani R, Caruso A. Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol. Mol Cell Endocrinol. 2002 Jun 28; 192(1-2):187-95. PMID: 12088879.
      View in: PubMed
    49. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology. 2002 May; 143(5):1613-24. PMID: 11956142.
      View in: PubMed
    50. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology. 2001 Aug; 142(8):3426-34. PMID: 11459787.
      View in: PubMed
    51. Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT. Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem. 2001 May 25; 276(21):17718-26. PMID: 11279126.
      View in: PubMed
    52. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab. 2001 Jan; 86(1):330-6. PMID: 11232020.
      View in: PubMed
    53. Schneyer AL, Fujiwara T, Fox J, Welt CK, Adams J, Messerlian GM, Taylor AE. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab. 2000 Sep; 85(9):3319-30. PMID: 10999828.
      View in: PubMed
    54. Wang Q, Keutmann HT, Schneyer AL, Sluss PM. Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins. Endocrinology. 2000 Sep; 141(9):3183-93. PMID: 10965889.
      View in: PubMed
    55. Delbaere A, Sidis Y, Schneyer AL. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin. Endocrinology. 1999 Jun; 140(6):2463-70. PMID: 10342830.
      View in: PubMed
    56. Sidis Y, Fujiwara T, Leykin L, Isaacson K, Toth T, Schneyer AL. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes. Biol Reprod. 1998 Oct; 59(4):807-12. PMID: 9746729.
      View in: PubMed
    57. Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung CJ, Zhang Z, Ying SY, Schneyer AL, Lauchlan SC, Felix JC. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol Oncol. 1998 Apr; 69(1):23-31. PMID: 9570994.
      View in: PubMed
    58. McConnell DS, Wang Q, Sluss PM, Bolf N, Khoury RH, Schneyer AL, Midgley AR, Reame NE, Crowley WF, Padmanabhan V. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab. 1998 Mar; 83(3):851-8. PMID: 9506739.
      View in: PubMed
    59. Di Simone N, Hall HA, Welt C, Schneyer AL. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells. Endocrinology. 1998 Mar; 139(3):1147-55. PMID: 9492049.
      View in: PubMed
    60. Welt CK, Lambert-Messerlian G, Zheng W, Crowley WF, Schneyer AL. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J Clin Endocrinol Metab. 1997 Nov; 82(11):3720-7. PMID: 9360531.
      View in: PubMed
    61. Lambert-Messerlian GM, Steinhoff M, Zheng W, Canick JA, Gajewski WH, Seifer DB, Schneyer AL. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecol Oncol. 1997 Jun; 65(3):512-6. PMID: 9190984.
      View in: PubMed
    62. Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF, Sluss PM. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology. 1996 Dec; 137(12):5476-83. PMID: 8940374.
      View in: PubMed
    63. Besecke LM, Guendner MJ, Schneyer AL, Bauer-Dantoin AC, Jameson JL, Weiss J. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology. 1996 Sep; 137(9):3667-73. PMID: 8756531.
      View in: PubMed
    64. Seifer DB, Freeman MR, Gardiner AC, Hill GA, Schneyer AL, Vanderhyden BC. Autologous granulosa cell coculture demonstrates zygote suppression of granulosa cell steroidogenesis. Fertil Steril. 1996 Sep; 66(3):425-9. PMID: 8751742.
      View in: PubMed
    65. Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley AR, Schneyer AL, Crowley WF, Sluss PM. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab. 1996 Apr; 81(4):1434-41. PMID: 8636347.
      View in: PubMed
    66. Schneyer AL. Measurement of activin in physiological fluids. Eur J Endocrinol. 1996 Apr; 134(4):401-2. PMID: 8640284.
      View in: PubMed
    67. Seifer DB, Lambert-Messerlian GM, Canick JA, Frishman GN, Schneyer AL. Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies. Fertil Steril. 1996 Mar; 65(3):667-9. PMID: 8774307.
      View in: PubMed
    68. Seifer DB, Gardiner AC, Lambert-Messerlian G, Schneyer AL. Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J Clin Endocrinol Metab. 1996 Feb; 81(2):736-9. PMID: 8636296.
      View in: PubMed
    69. Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology. 1996 Feb; 137(2):486-94. PMID: 8593793.
      View in: PubMed
    70. Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P, Crowley WF. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically. Endocrinology. 1996 Jan; 137(1):240-7. PMID: 8536619.
      View in: PubMed
    71. Lambert-Messerlian GM, Canick JA, Palomaki GE, Schneyer AL. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy. J Med Screen. 1996; 3(2):58-62. PMID: 8849760.
      View in: PubMed
    72. Good TE, Weber PS, Ireland JL, Pulaski J, Padmanabhan V, Schneyer AL, Lambert-Messerlian G, Ghosh BR, Miller WL, Groome N, et al. Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin. Biol Reprod. 1995 Dec; 53(6):1478-88. PMID: 8562706.
      View in: PubMed
    73. Lambert-Messerlian GM, Crowley WF, Schneyer AL. Extragonadal alpha-inhibin precursor proteins circulate in human male serum. J Clin Endocrinol Metab. 1995 Oct; 80(10):3043-9. PMID: 7559894.
      View in: PubMed
    74. Khoury RH, Wang QF, Crowley WF, Hall JE, Schneyer AL, Toth T, Midgley AR, Sluss PM. Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab. 1995 Apr; 80(4):1361-8. PMID: 7714112.
      View in: PubMed
    75. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley WF. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology. 1994 Aug; 135(2):667-74. PMID: 8033815.
      View in: PubMed
    76. Lambert-Messerlian GM, Hall JE, Sluss PM, Taylor AE, Martin KA, Groome NP, Crowley WF, Schneyer AL. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 1994 Jul; 79(1):45-50. PMID: 8027251.
      View in: PubMed
    77. Lambert-Messerlian GM, Isaacson K, Crowley WF, Sluss P, Schneyer AL. Human follicular fluid contains pro- and C-terminal immunoreactive alpha-inhibin precursor proteins. J Clin Endocrinol Metab. 1994 Feb; 78(2):433-9. PMID: 7508950.
      View in: PubMed
    78. Sluss PM, Gentile DP, Ewing JF, Schoen SR, Cockett AT, Martin KA, Schneyer AL. Multiple molecular weight forms of immunoreactive alpha-inhibin in human seminal plasma. J Clin Endocrinol Metab. 1993 Feb; 76(2):476-83. PMID: 8432793.
      View in: PubMed
    79. Sluss PM, Schneyer AL. Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients. J Clin Endocrinol Metab. 1992 Jun; 74(6):1242-6. PMID: 1592865.
      View in: PubMed
    80. Schneyer AL, O'Neil DA, Crowley WF. Activin-binding proteins in human serum and follicular fluid. J Clin Endocrinol Metab. 1992 Jun; 74(6):1320-4. PMID: 1592877.
      View in: PubMed
    81. Santoro N, Schneyer AL, Ibrahim J, Schmidt CL. Gonadotropin and inhibin concentrations in early pregnancy in women with and without corpora lutea. Obstet Gynecol. 1992 Apr; 79(4):579-85. PMID: 1553181.
      View in: PubMed
    82. Schneyer AL, Sluss PM, Whitcomb RW, Martin KA, Sprengel R, Crowley WF. Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology. 1991 Oct; 129(4):1987-99. PMID: 1915079.
      View in: PubMed
    83. Whitcomb RW, Schneyer AL, Roser JF, Hughes JP. Circulating antagonist of luteinizing hormone in association with infertility in stallions. Endocrinology. 1991 May; 128(5):2497-502. PMID: 2019262.
      View in: PubMed
    84. Schneyer AL, Sluss PM, Whitcomb RW, Hall JE, Crowley WF, Freeman RG. Development of a radioligand receptor assay for measuring follitropin in serum: application to premature ovarian failure. Clin Chem. 1991 Apr; 37(4):508-14. PMID: 1901773.
      View in: PubMed
    85. Landy H, Boepple PA, Mansfield MJ, Whitcomb RW, Schneyer AL, Crawford JD, Crigler JF, Crowley WF. Altered patterns of pituitary secretion and renal excretion of free alpha-subunit during gonadotropin-releasing hormone agonist-induced pituitary desensitization. J Clin Endocrinol Metab. 1991 Mar; 72(3):711-7. PMID: 1997524.
      View in: PubMed
    86. Sluss PM, Ewing JF, Schneyer AL. Phospholipase C-mediated release of low molecular weight follicle-stimulating hormone receptor-binding inhibitor from testis membranes. Biol Reprod. 1990 Dec; 43(6):1026-31. PMID: 2127230.
      View in: PubMed
    87. Bernstein JR, Crowley WF, Schneyer AL. An improved method of purifying inhibin radioligand for radioimmunoassay. Biol Reprod. 1990 Sep; 43(3):492-6. PMID: 2271731.
      View in: PubMed
    88. Whitcomb RW, Schneyer AL. Development and validation of a radioligand receptor assay for measurement of luteinizing hormone in human serum. J Clin Endocrinol Metab. 1990 Sep; 71(3):591-5. PMID: 2394770.
      View in: PubMed
    89. Schneyer AL, Mason AJ, Burton LE, Ziegner JR, Crowley WF. Immunoreactive inhibin alpha-subunit in human serum: implications for radioimmunoassay. J Clin Endocrinol Metab. 1990 Apr; 70(4):1208-12. PMID: 2318941.
      View in: PubMed
    90. Sluss PM, Schneyer AL, Andersen TT, Reichert LE. Purification and chemical composition of a low molecular weight follicle-stimulating hormone binding inhibitor from porcine follicular fluid. Biol Reprod. 1989 Nov; 41(5):863-70. PMID: 2516469.
      View in: PubMed
    91. Sluss PM, Schneyer AL, Cockett AT, Cromie WJ. Identification of a potential FSH modulatory protein in human testis and seminal plasma. J Androl. 1989 Sep-Oct; 10(5):386-92. PMID: 2512274.
      View in: PubMed
    92. Whitcomb RW, Sangha JS, Schneyer AL, Crowley WF. Improved measurement of free alpha subunit of glycoprotein hormones by assay with use of a monoclonal antibody. Clin Chem. 1988 Oct; 34(10):2022-5. PMID: 2458863.
      View in: PubMed
    93. Schneyer AL, Reichert LE, Franke M, Ryan RJ, Sluss PM. Follicle-stimulating hormone (FSH) immunoactivity in porcine follicular fluid is not pituitary FSH. Endocrinology. 1988 Jul; 123(1):487-91. PMID: 2454808.
      View in: PubMed
    94. Schneyer AL, Sluss PM, Huston JS, Ridge RJ, Reichert LE. Identification of a receptor binding region on the beta subunit of human follicle-stimulating hormone. Biochemistry. 1988 Jan 26; 27(2):666-71. PMID: 3126813.
      View in: PubMed
    95. Sluss PM, Schneyer AL, Franke MA, Reichert LE. Porcine follicular fluid contains both follicle-stimulating hormone agonist and antagonist activities. Endocrinology. 1987 Apr; 120(4):1477-81. PMID: 3104012.
      View in: PubMed
    96. Schneyer AL, Sluss PM, Bosukonda D, Reichert LE. Electrophoretic purification of radioiodinated follicle-stimulating hormone for radioligand receptor assay and radioimmunoassay. Endocrinology. 1986 Oct; 119(4):1446-53. PMID: 3093191.
      View in: PubMed
    For assistance with using Profiles, please contact Profiles Support
    Schneyer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _